Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Nov:10:100237.
doi: 10.1016/j.lanepe.2021.100237. Epub 2021 Oct 25.

Humoral immunity to SARS-CoV-2 vaccination in haemodialysis patients: (Response to: Humoral and cellular immunity to SARS-CoV-2 vaccination in renal transplant versus dialysis patients: A prospective, multicenter observational study using mRNA-1273 or BNT162b2 mRNA vaccine.)

Sandra Hasmann  1 , Michael Paal  2 , Louise Füeßl  1 , Michael Fischereder  1 , Ulf Schönermarck  1
Affiliations

Humoral immunity to SARS-CoV-2 vaccination in haemodialysis patients: (Response to: Humoral and cellular immunity to SARS-CoV-2 vaccination in renal transplant versus dialysis patients: A prospective, multicenter observational study using mRNA-1273 or BNT162b2 mRNA vaccine.)

Sandra Hasmann et al. Lancet Reg Health Eur. 2021 Nov.
No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors have nothing to disclose.

References

    1. Stumpf J, Siepmann T, Lindner T. Humoral and cellular immunity to SARS-CoV-2 vaccination in renal transplant versus dialysis patients: a prospective, multicenter observational study using mRNA-1273 or BNT162b2 mRNA vaccine. Lancet Reg Health Eur. 2021;000 doi: 10.1016/j.lanepe.2021.100178. - DOI - PMC - PubMed
    1. Paal M, Arend FM, Lau T. Antibody response to mRNA SARS-CoV-2 vaccines in hemodialysis patients. Clin Kidney J. 2021;1 doi: 10.1093/ckj/sfab127. - DOI - PMC - PubMed
    1. Chan L, Fuca N, Zeldis E, Campbell KN, Shaikh A. Antibody response to mRNA-1273 SARS-CoV-2 vaccine in hemodialysis patients with and without prior COVID-19. Clin J Am Soc Nephrol. 2021;16(8):1258–1260. doi: 10.2215/cjn.04080321. - DOI - PMC - PubMed
    1. Attias P, Sakhi H, Rieu P. Antibody response to the BNT162b2 vaccine in maintenance hemodialysis patients. Kidney Int. 2021;99(6):1490–1492. doi: 10.1016/J.KINT.2021.04.009. - DOI - PMC - PubMed
    1. Sakhi H, Dahmane D, Attias P. Kinetics of anti–SARS-CoV-2 IgG antibodies in hemodialysis patients six months after infection. J Am Soc Nephrol. 2021 doi: 10.1681/ASN.2020111618. Published online February 26ASN.2020111618. - DOI - PMC - PubMed